These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 24696044)

  • 1. Topical 0.03% tacrolimus for subepithelial infiltrates secondary to adenoviral keratoconjunctivitis.
    Levinger E; Trivizki O; Shachar Y; Levinger S; Verssano D
    Graefes Arch Clin Exp Ophthalmol; 2014 May; 252(5):811-6. PubMed ID: 24696044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical treatment with 1% cyclosporine for subepithelial infiltrates secondary to adenoviral keratoconjunctivitis.
    Levinger E; Slomovic A; Sansanayudh W; Bahar I; Slomovic AR
    Cornea; 2010 Jun; 29(6):638-40. PubMed ID: 20458220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporine a 0.05% eye drops for the treatment of subepithelial infiltrates after epidemic keratoconjunctivitis.
    Okumus S; Coskun E; Tatar MG; Kaydu E; Yayuspayi R; Comez A; Erbagci I; Gurler B
    BMC Ophthalmol; 2012 Aug; 12():42. PubMed ID: 22900547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tacrolimus for the treatment of subepithelial infiltrates resistant to topical steroids after adenoviral keratoconjunctivitis.
    Ghanem RC; Vargas JF; Ghanem VC
    Cornea; 2014 Nov; 33(11):1210-3. PubMed ID: 25188789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical Tacrolimus for Corneal Subepithelial Infiltrates Secondary to Adenoviral Keratoconjunctivitis.
    Berisa Prado S; Riestra Ayora AC; Lisa Fernández C; Chacón Rodríguez M; Merayo-Lloves J; Alfonso Sánchez JF
    Cornea; 2017 Sep; 36(9):1102-1105. PubMed ID: 28704319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the safety and efficacy of topical Tacrolimus (0.03%) versus dexamethasone (0.05%) for subepithelial infiltrates after adenoviral conjunctivitis.
    Bhargava R; Kumar P
    Indian J Ophthalmol; 2019 May; 67(5):594-598. PubMed ID: 31007215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late-term topical tacrolimus for subepithelial infiltrates resistant to topical steroids and ciclosporin secondary to adenoviral keratoconjunctivitis.
    Arici C; Mergen B
    Br J Ophthalmol; 2021 May; 105(5):614-618. PubMed ID: 32563992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporine A 1% eye drops for the treatment of subepithelial infiltrates after adenoviral keratoconjunctivitis.
    Jeng BH; Holsclaw DS
    Cornea; 2011 Sep; 30(9):958-61. PubMed ID: 21673568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical treatment of acute adenoviral keratoconjunctivitis with 0.2% cidofovir and 1% cyclosporine: a controlled clinical pilot study.
    Hillenkamp J; Reinhard T; Ross RS; Böhringer D; Cartsburg O; Roggendorf M; De Clercq E; Godehardt E; Sundmacher R
    Arch Ophthalmol; 2001 Oct; 119(10):1487-91. PubMed ID: 11594949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticosteroids Versus Cyclosporine for Subepithelial Infiltrates Secondary to Epidemic Keratoconjunctivitis: A Prospective Randomized Double-Blind Study.
    Gouider D; Khallouli A; Maalej A; Yousfi MA; Ksiaa I; Bouguerra C; Ajili F; Khairallah M
    Cornea; 2021 Jun; 40(6):726-732. PubMed ID: 33201059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pentacam corneal densitometry-guided treatment of adenoviral corneal subepithelial infiltrates: a comparative study between transepithelial phototherapeutic keratectomy and topical tacrolimus.
    Elhamaky TR
    Int Ophthalmol; 2021 Jan; 41(1):67-77. PubMed ID: 32852646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of cidofovir 1% with and without cyclosporin a 1% as a topical treatment of acute adenoviral keratoconjunctivitis: a controlled clinical pilot study.
    Hillenkamp J; Reinhard T; Ross RS; Böhringer D; Cartsburg O; Roggendorf M; De Clercq E; Godehardt E; Sundmacher R
    Ophthalmology; 2002 May; 109(5):845-50. PubMed ID: 11986086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tacrolimus ointment 0.03% for treatment of refractory childhood phlyctenular keratoconjunctivitis.
    Kymionis GD; Kankariya VP; Kontadakis GA
    Cornea; 2012 Aug; 31(8):950-2. PubMed ID: 22525784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical tacrolimus ointment for treatment of refractory anterior segment inflammatory disorders.
    Joseph MA; Kaufman HE; Insler M
    Cornea; 2005 May; 24(4):417-20. PubMed ID: 15829797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of clinical outcome with different treatment regimens in acute adenoviral keratoconjunctivitis.
    Asena L; Şıngar Özdemir E; Burcu A; Ercan E; Çolak M; Altınörs DD
    Eye (Lond); 2017 May; 31(5):781-787. PubMed ID: 28157224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptomatic Treatment of Subepithelial Infiltrates after Viral Conjunctivitis: Loteprednol or Dexamethasone?
    Koçluk Y; Sukgen EA; Cevher S; Mat E
    Ocul Immunol Inflamm; 2017 Oct; 25(5):649-653. PubMed ID: 27015587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tacrolimus Ointment for Treatment of Vernal Keratoconjunctivitis.
    Al-Amri AM; Mirza AG; Al-Hakami AM
    Middle East Afr J Ophthalmol; 2016; 23(1):135-8. PubMed ID: 26957853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photorefractive keratectomy for myopia in the setting of adenoviral subepithelial infiltrates.
    Fite SW; Chodosh J
    Am J Ophthalmol; 1998 Dec; 126(6):829-31. PubMed ID: 9860010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in Higher-Order Aberrations After Phototherapeutic Keratectomy for Subepithelial Corneal Infiltrates After Epidemic Keratoconjunctivitis.
    Kepez Yildiz B; Urvasizoglu S; Yildirim Y; Agca A; K Besek N; Fazil K; Eris E; Aygit ED; Taskapili M; Demirok A
    Cornea; 2017 Oct; 36(10):1233-1236. PubMed ID: 28742618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tacrolimus ointment in the management of atopic keratoconjunctivitis].
    Benaim D; Tétart F; Bauvin O; Delcampe A; Joly P; Muraine M; Gueudry J
    J Fr Ophtalmol; 2019 May; 42(5):435-440. PubMed ID: 30935698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.